CL2008000139A1 - Modificacion de cristales de astaxantina; proceso de preparacion; formulacion que la comprende; proceso para producir la formulacion; y uso para la nutricion humana o animal. - Google Patents
Modificacion de cristales de astaxantina; proceso de preparacion; formulacion que la comprende; proceso para producir la formulacion; y uso para la nutricion humana o animal.Info
- Publication number
- CL2008000139A1 CL2008000139A1 CL200800139A CL2008000139A CL2008000139A1 CL 2008000139 A1 CL2008000139 A1 CL 2008000139A1 CL 200800139 A CL200800139 A CL 200800139A CL 2008000139 A CL2008000139 A CL 2008000139A CL 2008000139 A1 CL2008000139 A1 CL 2008000139A1
- Authority
- CL
- Chile
- Prior art keywords
- formulation
- astaxantine
- understands
- crystals
- modification
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 2
- 239000000203 mixture Substances 0.000 title 2
- 235000019728 animal nutrition Nutrition 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
- A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Marine Sciences & Fisheries (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Insects & Arthropods (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07100801 | 2007-01-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008000139A1 true CL2008000139A1 (es) | 2008-05-23 |
Family
ID=39366121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200800139A CL2008000139A1 (es) | 2007-01-19 | 2008-01-17 | Modificacion de cristales de astaxantina; proceso de preparacion; formulacion que la comprende; proceso para producir la formulacion; y uso para la nutricion humana o animal. |
Country Status (2)
Country | Link |
---|---|
CL (1) | CL2008000139A1 (de) |
WO (1) | WO2008087090A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110180010A1 (en) * | 2008-05-30 | 2011-07-28 | Jingfei Guo | Crystal forms of astaxanthin |
ES2361276T5 (es) | 2007-01-16 | 2017-06-09 | Basf Se | Formulaciones líquidas, que contienen carotenoides |
CN105077203A (zh) | 2007-11-29 | 2015-11-25 | 巴斯夫欧洲公司 | 用于饮料着色的粉状类胡萝卜素制剂 |
CN102176833B (zh) | 2008-10-07 | 2018-03-16 | 巴斯夫欧洲公司 | 即用型稳定乳液 |
EP2792246A1 (de) | 2013-04-17 | 2014-10-22 | Basf Se | Verfahren zur Herstellung einer Astaxanthin-Suspension |
WO2015067711A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59912915D1 (de) * | 1998-08-05 | 2006-01-19 | Dsm Ip Assets Bv | Herstellung von 4,4'-Diketo-carotinoiden |
CN101243032B (zh) * | 2005-08-15 | 2012-10-10 | 法雷斯药品研究公司 | 虾青素的晶型 |
-
2008
- 2008-01-10 WO PCT/EP2008/050244 patent/WO2008087090A1/de active Application Filing
- 2008-01-17 CL CL200800139A patent/CL2008000139A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008087090A1 (de) | 2008-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008001334A1 (es) | Anticuerpo anti-muc16 disenado con cisteina; conjugado que lo comprende; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar el cancer. | |
CL2009001484A1 (es) | Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia. | |
CL2007002128A1 (es) | Derivados de n'-ciano-n-halogenoalquil-imidamida; procedimiento para la preparacion de dicho compuesto; composiciones farmaceuticas que lo contienen; y uso del compuesto para combatir parasitos animales. | |
BRPI0913063A2 (pt) | Compostos acilaminoácidos e preparações de alimentos que contém os mesmos | |
BRPI0821688A2 (pt) | mistura para o tratamento de fertilizantes contendo uréia | |
CL2007003187A1 (es) | Compuestos derivados de bencil-benzonitrilo sustituido con glucopiranosilo y sus sales; procedimiento de preparacion; compuestos intermediarios; proceso para preparar los compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de | |
CL2013001604A1 (es) | Compuestos derivados de pirimidinona sustituida; composicion farmaceutica que los comprende; su uso para tratar la enfermedad de alzheimer y la aterosclerosis. | |
CL2013001282A1 (es) | Sal succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxilico; composicion farmaceutica que la comprende y procesos para su preparacion. | |
CL2013001947A1 (es) | Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona. | |
DK2227539T3 (da) | Sammensætning til menneske- og/eller dyreernæring, anvendelser deraf og gær | |
BRPI0817812A2 (pt) | Uso de anticorpos trkb para o tratamento de distúrbios respiratórios | |
BRPI0809667A2 (pt) | Composto, medicamento e composição farmacêutica que o contém e uso do composto | |
CR10406A (es) | Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen | |
BR112012016398A2 (pt) | Composto imidazopiridinil-aminopiridino substituído, composição farmacêutica que compreende o referido composto e uso do mesmo para o tratamento de uma doença celular proliferativa | |
BRPI0820568A2 (pt) | Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal | |
CL2014002348A1 (es) | Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado. | |
BRPI0917661A2 (pt) | produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan | |
BRPI0819821A2 (pt) | Preparação e uso de polianilinas para tratamento de água | |
CL2008000887A1 (es) | Compuestos derivados de 3-hidroxi-1h-pirimidin-4-ona o 3-hidroxi-piran-4-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad neurodegenerativa causada por la presencia de | |
LT2400943T (lt) | Kosmetinė arba farmacinė emulsija odai, sumaišytina prieš pat naudojimą | |
BRPI0915439A2 (pt) | composição tópica para o tratamento de ceratose actínica | |
BR112012001344A2 (pt) | derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças | |
BRPI1009781A2 (pt) | compostos para o tratamento de distúrbios metabólicos, composição farmacêutica que os compreende e uso dos mesmos | |
CR10229A (es) | Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
BRPI0922233A2 (pt) | compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas. |